Treatment acceptance influences adherence

Non-Acceptance of treatment with anti depressants SSRI (Selective Serotonin Reuptake Inhibitor) leads to Non-Adherence a study carried out by Erica CG van Geffen, PharmD, and Rolf van Hulten, PharmD PhD,  Marcel L Bouvy, PharmD PhD, Antoine CG Egberts, PharmD PhD,  Eibert R Heerdink, PhD reveals and concludes that acceptance of SSRI treatment is a decisive moment in a patient's adherence to treatment initiated by his or her GP and deserves more attention; GPs and pharmacists should address treatment issues, especially in groups at risk for non acceptance.

Reprints:
Dr. Heerdink, Division of Pharmacoepidemiology and Pharmacotherapy, Utrecht Institute for Pharmaceutical Sciences, Faculty of Science, Utrecht University, PO Box 80082, 3508 TB, Utrecht, Netherlands, fax 31 30 253 9166, e.r.heerdink@uu.nl